Literature DB >> 15365816

FISH diagnosis of the common 57-kb deletion in CTNS causing cystinosis.

Claude Bendavid1, Robert Kleta, Robert Long, Maia Ouspenskaia, Maximilian Muenke, Bassem R Haddad, William A Gahl.   

Abstract

Cystinosis is an autosomal recessive lysosomal storage disease caused by mutations in CTNS. The most prevalent CTNS mutation, a 57-kb deletion, occurs in approximately 60% of patients in the United States and northern Europe and removes exons 1-9, most of exon 10, the CTNS promoter region, and all of an adjacent gene of unknown function called CARKL. CTNS codes for the lysosomal cystine transporter, whose absence leads to intracellular cystine accumulation, widespread cellular destruction, renal Fanconi syndrome in infancy, renal glomerular failure in later childhood, and other systemic complications. Because treatment with oral cysteamine can prevent or delay these complications significantly, early and accurate diagnosis is critical. This study describes the generation of fluorescence in situ hybridization (FISH) probes for the 57-kb deletion in CTNS, enabling cytogenetics laboratories to test for this common mutation. The probes would also be able to detect a less frequent 11.7-kb deletion. A blinded study was performed using multiplex PCR analysis as the gold standard to determine the presence or absence of the 57-kb deletion. The FISH probes, evaluated on 12 lymphoblastoid cell lines from singly deleted, doubly deleted, and nondeleted patients, made the correct diagnosis in every case. This appears to be the first FISH-based diagnostic method described for any lysosomal storage disorder. It can assist in the antenatal and perinatal diagnosis of cystinosis and promote earlier salutary therapy with cysteamine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365816     DOI: 10.1007/s00439-004-1170-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Prenatal diagnosis of spinal muscular atrophy by direct molecular analysis: efficacy and potential pitfalls.

Authors:  J M Milunsky; S M Cheney
Journal:  Genet Test       Date:  1999

2.  Assignment1 of STAT1 to human chromosome 2q32 by FISH and radiation hybrids.

Authors:  B Haddad; C R Pabón-Peña; H Young; W H Sun
Journal:  Cytogenet Cell Genet       Date:  1998

3.  Prenatal diagnosis of cystinosis utilizing chorionic villus sampling.

Authors:  M L Smith; O L Pellett; M M Cass; N G Kennaway; N R Buist; J Buckmaster; M Golbus; G S Spear; J A Schneider
Journal:  Prenat Diagn       Date:  1987       Impact factor: 3.050

Review 4.  Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.

Authors:  W A Gahl; E M Kuehl; F Iwata; A Lindblad; M I Kaiser-Kupfer
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

5.  Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay.

Authors:  L Forestier; G Jean; M Attard; S Cherqui; C Lewis; W van't Hoff; M Broyer; M Town; C Antignac
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

6.  A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis.

Authors:  M Town; G Jean; S Cherqui; M Attard; L Forestier; S A Whitmore; D F Callen; O Gribouval; M Broyer; G P Bates; W van't Hoff; C Antignac
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

7.  Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS).

Authors:  Y Anikster; C Lucero; J W Touchman; M Huizing; G McDowell; V Shotelersuk; E D Green; W A Gahl
Journal:  Mol Genet Metab       Date:  1999-02       Impact factor: 4.797

8.  CTNS mutations in an American-based population of cystinosis patients.

Authors:  V Shotelersuk; D Larson; Y Anikster; G McDowell; R Lemons; I Bernardini; J Guo; J Thoene; W A Gahl
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

9.  Classic nephropathic cystinosis as an adult disease.

Authors:  D S Theodoropoulos; D Krasnewich; M I Kaiser-Kupfer; W A Gahl
Journal:  JAMA       Date:  1993-11-10       Impact factor: 56.272

10.  Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal?

Authors:  R L Pisoni; J G Thoene; H N Christensen
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

View more
  8 in total

1.  Molecular evaluation of foetuses with holoprosencephaly shows high incidence of microdeletions in the HPE genes.

Authors:  Claude Bendavid; Christèle Dubourg; Isabelle Gicquel; Laurent Pasquier; Pascale Saugier-Veber; Marie-Renée Durou; Sylvie Jaillard; Thierry Frébourg; Bassem R Haddad; Catherine Henry; Sylvie Odent; Véronique David
Journal:  Hum Genet       Date:  2005-12-02       Impact factor: 4.132

2.  Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis.

Authors:  Tobias Fleige; Siegfried Burggraf; Ludwig Czibere; Julia Häring; Birgit Glück; Lisa Marie Keitel; Olfert Landt; Erik Harms; Katharina Hohenfellner; Jürgen Durner; Wulf Röschinger; Marc Becker
Journal:  Eur J Hum Genet       Date:  2019-09-30       Impact factor: 4.246

3.  Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2013-11-06

4.  Array-based Identification of Copy Number Changes in a Diagnostic Setting: Simultaneous gene-focused and low resolution whole human genome analysis.

Authors:  Renate Marquis-Nicholson; Elaine Doherty; Jennifer M Love; Chuan-Ching Lan; Alice M George; Anthony Thrush; Donald R Love
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

Review 5.  Cystinosis: a review.

Authors:  Mohamed A Elmonem; Koenraad R Veys; Neveen A Soliman; Maria van Dyck; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  Orphanet J Rare Dis       Date:  2016-04-22       Impact factor: 4.123

6.  Gene Dosage Analysis in a Clinical Environment: Gene-Targeted Microarrays as the Platform-of-Choice.

Authors:  Renate Marquis-Nicholson; Debra Prosser; Jennifer M Love; Donald R Love
Journal:  Microarrays (Basel)       Date:  2013-03-27

Review 7.  Inherited glomerular diseases in the gilded age of genomic advancements.

Authors:  Ashima Gulati; Neera Dahl; Alda Tufro
Journal:  Pediatr Nephrol       Date:  2019-05-03       Impact factor: 3.714

Review 8.  Detection of Structural Variants by NGS: Revealing Missing Alleles in Lysosomal Storage Diseases.

Authors:  Valentina La Cognata; Sebastiano Cavallaro
Journal:  Biomedicines       Date:  2022-07-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.